BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 22537210)

  • 21. Hemorheological aspects of the metabolic syndrome: markers of insulin resistance, obesity or hyperinsulinemia?
    Brun JF; Aloulou I; Varlet-Marie E
    Clin Hemorheol Microcirc; 2004; 30(3-4):203-9. PubMed ID: 15258344
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Insulin breast cancer connection: confirmatory data set the stage for better care.
    DeCensi A; Gennari A
    J Clin Oncol; 2011 Jan; 29(1):7-10. PubMed ID: 21115871
    [No Abstract]   [Full Text] [Related]  

  • 23. Implications of the hyperinsulinaemia-diabetes-cancer link for preventive efforts.
    Moore MA; Park CB; Tsuda H
    Eur J Cancer Prev; 1998 Apr; 7(2):89-107. PubMed ID: 9818771
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Obesity and breast cancer.
    Stoll BA
    Int J Obes Relat Metab Disord; 1996 May; 20(5):389-92. PubMed ID: 8696416
    [TBL] [Abstract][Full Text] [Related]  

  • 25. A review of obesity, insulin resistance, and the role of exercise in breast cancer patients.
    Ghose A; Kundu R; Toumeh A; Hornbeck C; Mohamed I
    Nutr Cancer; 2015; 67(2):197-202. PubMed ID: 25625592
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Adiposity, type 2 diabetes and the metabolic syndrome in breast cancer.
    Vona-Davis L; Howard-McNatt M; Rose DP
    Obes Rev; 2007 Sep; 8(5):395-408. PubMed ID: 17716297
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Increased risk of relapse after breast cancer with exposure to organochlorine pollutants.
    Charlier CJ; Dejardin MT
    Bull Environ Contam Toxicol; 2007 Jan; 78(1):1-4. PubMed ID: 17333420
    [No Abstract]   [Full Text] [Related]  

  • 28. [Correlations of insulin resistance and neoplasms].
    Suba Z; Ujpál M
    Magy Onkol; 2006; 50(2):127-35. PubMed ID: 16888676
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Estrogen and insulin crosstalk: breast cancer risk implications.
    McCance KL; Jones RE
    Nurse Pract; 2003 May; 28(5):12-23; quiz 24-5. PubMed ID: 12792265
    [No Abstract]   [Full Text] [Related]  

  • 30. Insulin-resistance and benign prostatic hyperplasia: the connection.
    Vikram A; Jena G; Ramarao P
    Eur J Pharmacol; 2010 Sep; 641(2-3):75-81. PubMed ID: 20553919
    [TBL] [Abstract][Full Text] [Related]  

  • 31. A novel role for insulin resistance in the connection between obesity and postmenopausal breast cancer.
    Weichhaus M; Broom J; Wahle K; Bermano G
    Int J Oncol; 2012 Aug; 41(2):745-52. PubMed ID: 22614942
    [TBL] [Abstract][Full Text] [Related]  

  • 32. Metabolic syndrome, central obesity and insulin resistance are associated with adverse pathological features in postmenopausal breast cancer.
    Healy LA; Ryan AM; Carroll P; Ennis D; Crowley V; Boyle T; Kennedy MJ; Connolly E; Reynolds JV
    Clin Oncol (R Coll Radiol); 2010 May; 22(4):281-8. PubMed ID: 20189371
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Relationship of raised serum total and protein bound sialic acid levels with hyperinsulinemia and indices of insulin sensitivity and insulin resistance in non-diabetic normotensive obese subjects.
    Rajappa M; Ikkruthi S; Nandeesha H; Satheesh S; Sundar I; Ananthanarayanan PH; Harichandrakumar KT
    Diabetes Metab Syndr; 2013; 7(1):17-9. PubMed ID: 23517790
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Association between breast and colorectal cancers.
    Stoll BA
    Br J Surg; 1998 Nov; 85(11):1468-72. PubMed ID: 9823904
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Obesity-related proliferative diseases: the interaction between adipose tissue and estrogens in post-menopausal women.
    Vicennati V; Garelli S; Rinaldi E; Rosetti S; Zavatta G; Pagotto U; Pasquali R
    Horm Mol Biol Clin Investig; 2015 Jan; 21(1):75-87. PubMed ID: 25781553
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Serum insulin-like growth factor-I and platelet-derived growth factor as biomarkers of breast cancer prognosis.
    Pasanisi P; Venturelli E; Morelli D; Fontana L; Secreto G; Berrino F
    Cancer Epidemiol Biomarkers Prev; 2008 Jul; 17(7):1719-22. PubMed ID: 18628423
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Biochemical characteristics and risk factors for insulin resistance at different levels of obesity.
    Guerrero-Romero F; Aradillas-García C; Simental-Mendía LE; Torres-Rodríguez ML; Mendoza Ede L; Rosales-Cervantes J; Rodríguez-Ramírez G; Rodríguez-Moran M
    Pediatrics; 2013 Apr; 131(4):e1211-7. PubMed ID: 23478864
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Insulin resistance/hyperinsulinemia and cancer mortality: the Cremona study at the 15th year of follow-up.
    Perseghin G; Calori G; Lattuada G; Ragogna F; Dugnani E; Garancini MP; Crosignani P; Villa M; Bosi E; Ruotolo G; Piemonti L
    Acta Diabetol; 2012 Dec; 49(6):421-8. PubMed ID: 22215126
    [TBL] [Abstract][Full Text] [Related]  

  • 39. Obesity as a risk factor for development and poor prognosis of breast cancer.
    Carmichael AR
    BJOG; 2006 Oct; 113(10):1160-6. PubMed ID: 16945118
    [TBL] [Abstract][Full Text] [Related]  

  • 40. Diet and exercise regimens to improve breast carcinoma prognosis.
    Stoll BA
    Cancer; 1996 Dec; 78(12):2465-70. PubMed ID: 8952552
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 8.